ReNeuron Group (RENE) RNS Announcements

Add to Alert list
Date Time Source Announcement
01 Feb 2021 09:55 AM
RNS
Total Voting Rights
15 Jan 2021 02:06 PM
RNS
Second Price Monitoring Extn
15 Jan 2021 02:01 PM
RNS
Price Monitoring Extension
15 Jan 2021 07:00 AM
RNS
Clinical Update
06 Jan 2021 07:00 AM
RNS
Analyst Conference Call
18 Dec 2020 04:36 PM
RNS
Price Monitoring Extension
18 Dec 2020 07:00 AM
RNS
Notification of Major Holdings
17 Dec 2020 12:44 PM
RNS
Notification of Major Holdings
17 Dec 2020 07:00 AM
RNS
Notification of Major Holdings
17 Dec 2020 07:00 AM
RNS
Notification of Allowance granted for US Patent
16 Dec 2020 05:37 PM
RNS
Notification of Major Holdings
16 Dec 2020 02:17 PM
RNS
Notification of Major Holdings
16 Dec 2020 07:00 AM
RNS
Notification of Major Holdings
11 Dec 2020 10:33 AM
RNS
Result of General Meeting and Total Voting Rights
11 Dec 2020 07:00 AM
RNS
Result of Open Offer
25 Nov 2020 04:41 PM
RNS
Second Price Monitoring Extn
25 Nov 2020 04:36 PM
RNS
Price Monitoring Extension
25 Nov 2020 02:06 PM
RNS
Second Price Monitoring Extn
25 Nov 2020 02:00 PM
RNS
Price Monitoring Extension
25 Nov 2020 11:05 AM
RNS
Second Price Monitoring Extn
25 Nov 2020 11:00 AM
RNS
Price Monitoring Extension
24 Nov 2020 04:41 PM
RNS
Second Price Monitoring Extn
24 Nov 2020 04:36 PM
RNS
Price Monitoring Extension
24 Nov 2020 02:06 PM
RNS
Second Price Monitoring Extn
24 Nov 2020 02:00 PM
RNS
Price Monitoring Extension
24 Nov 2020 07:15 AM
RNS
Result of Placing and Subscription and GM Notice
24 Nov 2020 07:00 AM
RNS
Interim Results
23 Nov 2020 05:42 PM
RNS
Proposed Placing, Subscription and Open Offer
02 Nov 2020 07:00 AM
RNS
Total Voting Rights
10 Sep 2020 03:59 PM
RNS
Result of AGM
10 Sep 2020 07:00 AM
RNS
AGM Trading Update
01 Sep 2020 07:00 AM
RNS
Block Listing Review and Total Voting Rights
18 Aug 2020 07:00 AM
RNS
Posting of Annual Report and Notice of AGM
12 Aug 2020 07:00 AM
RNS
Changes to Non-Executive Board
03 Aug 2020 07:00 AM
RNS
Total Voting Rights
31 Jul 2020 07:00 AM
RNS
Notification of Allowance granted for US Patent
20 Jul 2020 07:00 AM
RNS
Preliminary Results
14 Jul 2020 03:06 PM
RNS
Notification of Major Holdings
29 Jun 2020 07:00 AM
RNS
Further Positive Data in Retinal Clinical Trial
25 Jun 2020 07:00 AM
RNS
New Exosome Research Collaboration
17 Jun 2020 07:00 AM
RNS
Regulatory Approvals and Programme Update
07 May 2020 07:00 AM
RNS
CTX cell line shows further potential
07 Apr 2020 02:06 PM
RNS
Second Price Monitoring Extn
07 Apr 2020 02:00 PM
RNS
Price Monitoring Extension
07 Apr 2020 11:06 AM
RNS
Second Price Monitoring Extn
07 Apr 2020 11:00 AM
RNS
Price Monitoring Extension
07 Apr 2020 07:00 AM
RNS
Exosome Research Collaboration
03 Apr 2020 07:00 AM
RNS
COVID-19 Update
16 Mar 2020 04:43 PM
RNS
Second Price Monitoring Extn
16 Mar 2020 04:39 PM
RNS
Price Monitoring Extension

ReNeuron Group plc is a United Kingdom-based clinical-stage stem cell company. The Company is engaged in the development of stem cell therapies targeting areas of unmet or poorly met medical need. It has developed a stem cell-derived, exosome-based, drug delivery platform with customizable cellular targeting capabilities for the delivery of complex drug modalities. Through the generation of several exosome producer cell lines, its CustomEX platform can be optimized for specific tissue targets and payloads, leading to improvements in therapeutic outcome and a reduction in off-target effects. It offers a delivery mechanism for a variety of payloads such as small interfering Ribonucleic Acid (siRNA), messenger RNA (mRNA), proteins, small molecules and genes. Through its conditionally immortalized induced pluripotent stem cell (iPSC) platform, it has the ability to make allogeneic tissue cells of choice and has the potential to produce exosomes with tissue specific targeting ability.

It listed on AIM in 2006 under the ticker RENE.

UK 100

Latest directors dealings